Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics

Abiraterone acetate (AA) has been proven effective for metastatic castration-resistant prostate cancer (mCRPC), and it has been proposed that adaptive AA may reduce toxicity and prolong time to progression, when compared to continuous AA. We developed a simple quantitative model of prostate-specific...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Renee Brady-Nicholls, Jingsong Zhang, Tian Zhang, Andrew Z. Wang, Robert Butler, Robert A. Gatenby, Heiko Enderling
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2021-09-01
Ráidu:	Neoplasia: An International Journal for Oncology Research
Fáttát:	Prostate cancer Metastatic Mathematical Modeling Predictive Adaptive therapy
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S1476558621000543
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!